The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of negative thyroid transcription factor (TTF-1) status to predict for negative epidermal growth factor receptor (EGFR) mutations (Mts) status with a high negative predictive value (NPV) in patients (pts) with adenocarcinomas (AC) of the lung.
N. Somaiah
Honoraria - Response Genetics
Research Funding - Response Genetics
E. Garrett-Mayer
No relevant relationships to disclose
X. Huang
Employment or Leadership Position - Response Genetics
A. E. Wahlquist
No relevant relationships to disclose
K. Danenberg
Employment or Leadership Position - Response Genetics
Stock Ownership - Response Genetics
G. R. Simon
Honoraria - Response Genetics
Research Funding - Response Genetics